Testosterone Replacement for Erectile Dysfunction
Testosterone replacement therapy (TRT) can help erectile dysfunction only in men with confirmed low testosterone levels who also have reduced sexual desire, but it will not cure erectile dysfunction on its own and provides modest benefits at best. 1
When TRT May Help ED
TRT is appropriate for ED patients with documented low testosterone levels (<300 ng/dL on two separate morning measurements) who specifically report reduced sexual desire and satisfaction. 1
The 2025 European Association of Urology guidelines explicitly state that hormonal treatment with testosterone (intramuscular, transdermal, or oral) can help ED patients with low testosterone levels experiencing reduced sexual desire and satisfaction. 1
However, the benefit is limited: a 2024 Cochrane review of 2,016 men found TRT likely results in little to no clinically meaningful difference in erectile function, with an improvement of only 2.37 points on the IIEF-EF scale—well below the 4-point threshold considered clinically significant. 2
The Evidence Shows Modest Sexual Benefits
The most recent high-quality evidence from the 2024 TRAVERSE trial (1,161 men followed for 2 years) demonstrated that TRT improved sexual activity and sexual desire but did not improve erectile function compared to placebo. 3
TRT provides small but significant improvements in sexual function and libido, with little to no effect on physical functioning, energy, or vitality according to the American College of Physicians. 4
The 2024 Cochrane review confirmed TRT likely results in little to no change in sexual quality of life (mean difference -2.31 on the Aging Males' Symptoms scale, below the 10-point threshold for clinical significance). 2
When TRT Alone Is Insufficient
For men with ED who fail to respond to PDE5 inhibitors (like sildenafil) and have low testosterone, combining TRT with PDE5 inhibitors may be more effective than either alone. 5
A 2004 multicenter study showed testosterone gel improved erectile response to sildenafil in hypogonadal men who previously did not respond to sildenafil alone. 5
However, a 2012 randomized trial of 140 men found that adding testosterone to sildenafil was not superior to sildenafil plus placebo in improving erectile function (difference 2.2 points, not statistically significant). 6
Critical Diagnostic Considerations
Never rely on total testosterone alone to exclude hypogonadism in ED patients, especially those over 60 years old. A 2023 study found 17.2% of ED patients had normal total testosterone but low free testosterone, with this rising to 26.3% in men over 60. 7
The European Association of Urology guidelines recommend measuring free testosterone by equilibrium dialysis in addition to total testosterone, especially when total testosterone is borderline. 4
Confirm persistent low testosterone through repeat morning measurements on two separate occasions, as single measurements are insufficient due to assay variability. 4
Who Should NOT Receive TRT for ED
Men with secondary hypogonadism who desire fertility should receive gonadotropin therapy—not testosterone—as TRT has inhibitory effects on spermatogenesis. 8
Absolute contraindications include active desire for fertility preservation, active or treated male breast cancer, prostate cancer, hematocrit >54%, and untreated severe obstructive sleep apnea. 4
TRT should not be commenced for 3-6 months in patients with a history of cardiovascular events. 8
Practical Treatment Algorithm
Step 1: Confirm hypogonadism
- Obtain two morning total testosterone measurements; both must be <300 ng/dL. 4, 8
- Measure free testosterone if total testosterone is 300-400 ng/dL or patient is over 60 years old. 4, 7
- Check LH and FSH to distinguish primary from secondary hypogonadism. 4
Step 2: Assess symptoms
- TRT is only indicated if the patient reports reduced sexual desire in addition to ED. 1
- If erectile function is the only complaint without reduced libido, TRT is unlikely to help. 3
Step 3: Choose formulation
- Transdermal preparations (gel or patch) are favored over intramuscular injections due to more stable day-to-day testosterone levels. 4, 8
- Target mid-normal testosterone levels (450-600 ng/dL). 4, 8
Step 4: Monitor response
- Check testosterone levels at 14 days and 28 days after starting treatment or after any dose adjustment. 4, 9
- Reassess clinical symptoms within 12 months; discontinue therapy if there is no improvement in sexual function. 9
- Monitor hematocrit periodically and withhold treatment if >54%. 4
Common Pitfalls to Avoid
Do not prescribe TRT for ED in men with normal testosterone levels. The 2024 Cochrane review excluded men without testosterone deficiency, and guidelines do not support this practice. 2
Do not expect TRT to cure erectile dysfunction. Even in hypogonadal men, TRT provides modest improvements in sexual desire but minimal improvement in erectile function itself. 2, 3
Do not overlook free testosterone in older men. Aging increases SHBG, which can cause symptomatic hypogonadism despite normal total testosterone. 7
Do not continue TRT indefinitely without symptom reassessment. If target testosterone levels are achieved but symptoms do not improve after 3-6 months, discontinue therapy. 9